Inactivation of γ‐secretases leads to accumulation of substrates and non‐Alzheimer neurodegeneration
Abstract γ‐Secretases are a family of intramembrane cleaving aspartyl proteases and important drug targets in Alzheimer's disease. Here, we generated mice deficient for all γ‐secretases in the pyramidal neurons of the postnatal forebrain by deleting the three anterior pharynx defective 1 (Aph1)...
Saved in:
| Main Authors: | Hermien Acx, Lutgarde Serneels, Enrico Radaelli, Serge Muyldermans, Cécile Vincke, Elise Pepermans, Ulrike Müller, Lucía Chávez‐Gutiérrez, Bart De Strooper |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2017-06-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.15252/emmm.201707561 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct
by: Yong Ran, et al.
Published: (2017-05-01) -
The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease
by: Gao Ning, et al.
Published: (2025-08-01) -
NGP 555, a γ‐secretase modulator, shows a beneficial shift in the ratio of amyloid biomarkers in human cerebrospinal fluid at safe doses
by: Maria Z. Kounnas, et al.
Published: (2019-01-01) -
New onset hidradenitis suppurativa and eruptive milia associated with gamma secretase inhibitor therapy in a patient with desmoid tumor: A case report
by: Yasmin Gutierrez, MD, et al.
Published: (2025-09-01) -
Generation and deposition of Aβ43 by the virtually inactive presenilin‐1 L435F mutant contradicts the presenilin loss‐of‐function hypothesis of Alzheimer's disease
by: Benedikt Kretner, et al.
Published: (2016-03-01)